Pál Perjési
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 10
- Organic Chemistry top 2%
- Synthesis and biological activity 47
- Synthesis and Biological Evaluation 16
- Free Radicals and Antioxidants 16
- Pharmacology top 2%
- Synthesis of Organic Compounds 23
- Biochemistry top 5%
- Pharmacology top 5%
- Synthesis of Organic Compounds 23
-
- Genomics, phytochemicals, and oxidative stress 16
-
- Toxin Mechanisms and Immunotoxins 9
-
- Drug Transport and Resistance Mechanisms 8
Pál Perjési
127 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Toxicology 142
- Organic Chemistry 1.1k
- Pharmacology 374
- Biochemistry 122
- Pharmacology 140
Countries citing papers authored by Pál Perjési
This map shows the geographic impact of Pál Perjési's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pál Perjési with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pál Perjési more than expected).
Fields of papers citing papers by Pál Perjési
This network shows the impact of papers produced by Pál Perjési. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pál Perjési. The network helps show where Pál Perjési may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pál Perjési, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | Glutathione-Related Enzymes and Proteins: A Reviewbreakdown → | 2023 | 178 |
| 5 | 2023 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2015 | 3 | |
| 8 | Enhanced effectiveness of conventional oncotherapy with plant immunomodulators: Overview of recent advances | 2013 | 2 |
| 9 | 2013 | 5 | |
| 10 | 2013 | 12 | |
| 11 | 2012 | 39 | |
| 12 | 2009 | 22 | |
| 13 | 2009 | 29 | |
| 14 | 2008 | 63 | |
| 15 | 2007 | 56 | |
| 16 | 2006 | 48 | |
| 17 | 2006 | 16 | |
| 18 | 2004 | 14 | |
| 19 | 1997 | 12 | |
| 20 | 1993 | 6 |
About Pál Perjési
Pál Perjési is a scholar working on Toxicology, Organic Chemistry, Pharmacology, Pharmacology and Biochemistry, having authored 132 papers that have together received 2.2k indexed citations. Recurring topics across this work include Synthesis and biological activity (47 papers), Synthesis of Organic Compounds (23 papers), Genomics, phytochemicals, and oxidative stress (16 papers), Synthesis and Biological Evaluation (16 papers), Free Radicals and Antioxidants (16 papers), Bioactive Compounds and Antitumor Agents (10 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). The work is most often cited by research in Toxicology (142 citations), Organic Chemistry (1.1k citations), Pharmacology (374 citations), Biochemistry (122 citations) and Pharmacology (140 citations). Pál Perjési has collaborated with scholars based in Hungary, Slovakia and Brazil. Frequent co-authors include Zsuzsanna Rozmer, László Prókai, Katalin Prókai-Tátrai, Janka Vašková, James W. Simpkins, Ladislav Vaško, Ladislav Kočan, Alevtina D. Zharikova, E Fischer and Ján Mojžíš. Their work appears in journals such as Molecules, Journal of Medicinal Chemistry, Toxicology in Vitro, Medicinal Chemistry Research and Journal of Chromatographic Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.